Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naoya Takeda

Showing results (121-130 of 123) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 123 results.
JTO Clinical and Research Reports|April 6, 2026
Efficacy and Safety of First-Line Ramucirumab Plus Erlotinib for <i>EGFR</i> L858R-Mutated NSCLC in Real-World Practice: A Retrospective Multicenter REAL-SPEED AnalysisMasashi Ishihara, Takahisa Kawamura, Yukiko Namba, et al.
Nature Communications|February 16, 2021
Genetic determinants of risk in autoimmune pulmonary alveolar proteinosisSaori Sakaue, Etsuro Yamaguchi, Yoshikazu Inoue, et al.
Nature Genetics|January 3, 2025
Blood DNA virome associates with autoimmune diseases and COVID-19Noah Sasa, Shohei Kojima, Rie Koide, et al.
Pageof 13

Showing results (121-130 of 123) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 123 results.
JTO Clinical and Research Reports|April 6, 2026
Efficacy and Safety of First-Line Ramucirumab Plus Erlotinib for <i>EGFR</i> L858R-Mutated NSCLC in Real-World Practice: A Retrospective Multicenter REAL-SPEED AnalysisMasashi Ishihara, Takahisa Kawamura, Yukiko Namba, et al.
Nature Communications|February 16, 2021
Genetic determinants of risk in autoimmune pulmonary alveolar proteinosisSaori Sakaue, Etsuro Yamaguchi, Yoshikazu Inoue, et al.
Nature Genetics|January 3, 2025
Blood DNA virome associates with autoimmune diseases and COVID-19Noah Sasa, Shohei Kojima, Rie Koide, et al.
Pageof 13